Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Gross Margin (2017 - 2025)

Nutex Health's Gross Margin history spans 16 years, with the latest figure at 30.42% for Q4 2025.

  • For Q4 2025, Gross Margin fell 2456.0% year-over-year to 30.42%; the TTM value through Dec 2025 reached 50.76%, up 987.0%, while the annual FY2025 figure was 50.76%, 987.0% up from the prior year.
  • Gross Margin for Q4 2025 was 30.42% at Nutex Health, down from 57.83% in the prior quarter.
  • Across five years, Gross Margin topped out at 2377.16% in Q1 2022 and bottomed at 93.21% in Q3 2022.
  • The 5-year median for Gross Margin is 28.73% (2024), against an average of 147.41%.
  • The largest annual shift saw Gross Margin skyrocketed 235597bps in 2022 before it crashed -236855bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 55.41% in 2021, then crashed by -98bps to 0.99% in 2022, then soared by 1821bps to 18.97% in 2023, then surged by 190bps to 54.98% in 2024, then plummeted by -45bps to 30.42% in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Gross Margin are 30.42% (Q4 2025), 57.83% (Q3 2025), and 51.2% (Q2 2025).